Alistair Duncan

Alistair Duncan

Direttore/Membro del Consiglio presso MADISON PACIFIC PROPERTIES INC.
Health Technology
Commercial Services
Finance

Profilo

Alistair Duncan was the founder of Chromos Molecular Systems, Inc., founded in 1998, where the title held was President & Chief Executive Officer in 2008.
Mr. Duncan is the founder of viDA Therapeutics, Inc., founded in 2008, holding the title of President & Chief Executive Officer since 2008.
Current jobs include Director at Metro Vancouver Properties Corp.
and Director at Madison Pacific Properties, Inc. starting in 2025.
Former jobs include Director at MIGENIX, Inc. from 2004 to 2010, Director at Global Gaming Technologies Corp.
from 2010 to 2012, Director at BC Technology Industry Association, Director at Michael Smith Foundation for Health Research, Principal at Ernst & Young LLP, Chief Financial Officer at Agrisoma Biosciences, Inc., and Member at The Institute of Chartered Accountants of British Columbia.
Education includes undergraduate studies at the University of British Columbia.

Posizioni attive di Alistair Duncan

SocietàPosizioneInizio
MADISON PACIFIC PROPERTIES INC. Direttore/Membro del Consiglio 30/09/2025
Amministratore Delegato 01/01/2008
Direttore/Membro del Consiglio -

Precedenti posizioni note di Alistair Duncan

SocietàPosizioneFine
Corporate Officer/Principal 22/10/2012
Direttore/Membro del Consiglio 24/03/2010
Fondatore 16/04/2008
Direttore Finanziario/CFO -
GLOBAL GAMING TECHNOLOGIES CORP. Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Alistair Duncan

Formazione di Alistair Duncan

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

45

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Commercial Services

Health Technology

Finance

Health Technology

Technology Services

Finance

Consumer Services

Process Industries

Commercial Services

BC Technology Industry Association

Miscellaneous

Health Technology

  1. Mercati
  2. Insiders
  3. Alistair Duncan